PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported February 1, 2017

Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside Poly-lined cardboard drums. Net weight 40 kg

Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.

Recall #
D-0447-2017
Affected scope
2351.12 pound container
Initiated
May 20, 2014
Verify with FDA Drug →
View my saved recalls

Cambrex Charles City Inc recalled Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in … — a moderate-severity action.

Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in … was recalled by Cambrex Charles City Inc in February 1, 2017. Reason: Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was…. Check the official notice for the remedy. Verify recall #D-0447-2017 with the FDA Drug before acting.

The recall

Cambrex Charles City Inc issued this moderate-severity FDA Drug recall — Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was….

Moderate
severity level
Class II
classification
February 1, 2017
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0447-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0447-2017) was formally reported on February 1, 2017, with the manufacturer initiating the action on May 20, 2014. It is classified under Moderate severity (Class II), with a current status of Terminated. Cambrex Charles City Inc is listed as the recalling firm, operating out of Charles City, IA. Federal records list the affected scope as 2351.12 pound container.

The documented reason for this recall is: Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product. Distribution data in the federal record shows the product reached: Product distributed solely to the state of Minnesota.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 4 from FDA Drug — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Vehicles recalls over time

Where this recall sits in its category — 9,301 vehicles recalls on record

02004006008001,000 20052008201120142017202020232026 109

Where this recall sits in the database

Severity2366872097High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger — we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

2351.12 pound container

Related Recalls

6

4 from same agency

Product description

Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside Poly-lined cardboard drums. Net weight 40 kg

Reason for recall

Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-0447-2017
Date reported February 1, 2017
Date initiated May 20, 2014
Recalling firm Cambrex Charles City Inc
Firm location Charles City, IA
Affected scope 2351.12 pound container
Distribution Product distributed solely to the state of Minnesota.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0447-2017) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting — recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside Poly-lined cardboard drums. Net weight 40 kg. Recalled by Cambrex Charles City Inc. Units affected: 2351.12 pound container.
Why was this product recalled?
Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2017. Severity: Moderate. Recall number: D-0447-2017.
Where was the recalled product distributed?
Distribution: Product distributed solely to the state of Minnesota..
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0447-2017) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distribut… →

Data Sources

Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Drug, reported February 1, 2017.

  • Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.